东海证券晨会纪要-20260211

Key Insights - The report highlights significant capital expenditure increases among the four major CSP manufacturers, driven by demand that is pushing up power semiconductor prices, indicating a robust recovery in the electronic sector [6][7] - The semiconductor industry is expected to reach a historic high in sales in 2025, with a projected increase in demand for computing power due to AI infrastructure investments [8] - The excavator market saw a substantial increase in both domestic and export sales in January 2026, indicating strong demand recovery in the machinery sector [13][14] - The small nucleic acid sector is gaining traction, with notable collaborations and sales growth, reflecting the increasing value of this market segment in the pharmaceutical industry [18][19] Group 1: Electronic Industry - The electronic sector is experiencing a recovery, with AI infrastructure investments leading to a surge in capital expenditures among major CSPs, expected to reach $670 billion in 2026, a 60% increase year-on-year [7] - The global semiconductor sales reached $791.7 billion in 2025, with a projected increase to over $1 trillion in 2026, driven by demand from AI and IoT technologies [8] - The price increase trend in semiconductors is spreading from memory chips to power, analog, and MCU chips, indicating a comprehensive price cycle in the semiconductor industry [8] Group 2: Machinery Industry - In January 2026, excavator sales increased by 49.5% year-on-year, with domestic sales up 61.4% and exports up 40.5%, reflecting strong demand recovery [13][14] - The loader market also saw significant growth, with sales increasing by 48.5% year-on-year, driven by major domestic projects and a growing overseas market [15] - The overall machinery industry is expected to continue its recovery, supported by government policies and infrastructure projects [14][15] Group 3: Pharmaceutical Industry - The small nucleic acid sector is highlighted for its potential, with a recent collaboration between Saint Gene and Gene Tech valued at up to $1.7 billion, showcasing the sector's growth and international recognition [19][20] - The pharmaceutical sector overall saw a slight increase of 0.14% in the last week, with certain sub-sectors like traditional Chinese medicine and medical services performing particularly well [18] - Investment opportunities are identified in biotech firms with core delivery technologies and those focusing on chronic disease areas, indicating a shift towards more sustainable growth in the pharmaceutical market [20]